Tenderwize
Back to tender search

Pharmaceutical products for Amgros 2027 tender

Amgros I/S·København Ø, Denmark·DKK 807M | EUR 108M·Deadline Aug 20, 2026 · 5 days left·Open·Supplies·Framework
High value
Original notice title

Denmark – Pharmaceutical products – Amgros 2027 1.1492.a

66/100

Opportunity Score

Needs reviewMedium complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

66 / 100

Complexity

58 / 100

Risk factors

Document URLs are provided, but no procurement document text was included, so key contractual terms, submission instruc...

The lots are based on estimated quantities and the notice explicitly says actual consumption may differ significantly.

Submission deadline in 5 days

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • DKK 807M estimated value
  • Framework procurement
  • Supplies contract
  • 3 lots
  • Duration until Mar 2030
  • Framework agreements for pharmaceutical products, specifically Leuprorelin (ATC L02AE02), for supply to hospital pharmacies of the participating Danish regions.
  • Possible resale to the Faroe Islands and Greenland is mentioned in the description.
Show full summary

Open framework agreement tender by Amgros I/S for pharmaceutical products (Leuprorelin, ATC L02AE02) in Denmark, split into 5 independent lots. Award is price-only. The notice states no minimum suitability requirements. Electronic submission is required. The tender is for hospital supply and possible resale to the Faroe Islands and Greenland, but the framework agreements are non-exclusive and without purchase obligation.

Risks

Document URLs are provided, but no procurement document text was included, so key contractual terms, submission instruc...

The lots are based on estimated quantities and the notice explicitly says actual consumption may differ significantly.

Submission deadline in 5 days

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Award criterion is price only (100%).
  • No minimum suitability requirements are stated in the structured data.

Administrative

  • Electronic submission is required.

Award Criteria

Lot 1

Price, 100% (per-exa)100%

Lot 2

Price, 100% (per-exa)100%

Lot 3

Price, 100% (per-exa)100%

Lot 4

Pris, Der henvises til udbudsbetingelserne pkt. 10100%

Lot 5

Pris, Der henvises til udbudsbetingelserne pkt. 10100%

Buyer

Location

København Ø, DNK

Buyer profile

Open profile

Identifier

14479880

Activity

Health

Lots (5)

LOT-0001

Leuprorelin depot injection 21 mg

Supply of Leuprorelin (ATC L02AE02) as depot injection solution, strength 21 mg, estimated quantity 9,999 units. The lot is an independent sub-contract and may be bid on separately. The notice says actual consumption may differ materially from the estimate.

SuppliesFrameworkEU fundedElectronic submission

EUR 108M

Estimated value

Location

DK011, Denmark

Duration

Mar 2027 - Mar 2030

Category

Pharmaceutical products

Award Criteria

Price

Deadline

Deadline Aug 20, 2026

LOT-0002

Leuprorelin injection 42 mg

Supply of Leuprorelin (ATC L02AE02) as injection solution, strength 42 mg, estimated quantity 9,999 units. Independent lot; bids may be submitted for one, several, or all lots. Actual consumption may differ materially from the estimate.

SuppliesFrameworkEU fundedElectronic submission

EUR 108M

Estimated value

Location

DK011, Denmark

Duration

Mar 2027 - Mar 2030

Category

Pharmaceutical products

Award Criteria

Price

Deadline

Deadline Aug 20, 2026

LOT-0003

Leuprorelin injection 7.5 mg

Supply of Leuprorelin (ATC L02AE02) as injection solution, strength 7.5 mg, estimated quantity 9,999 units. Independent lot; bids may be submitted for one, several, or all lots. Actual consumption may differ materially from the estimate.

SuppliesFrameworkEU fundedElectronic submission

EUR 108M

Estimated value

Location

DK011, Denmark

Duration

Mar 2027 - Mar 2030

Category

Pharmaceutical products

Award Criteria

Price

Deadline

Deadline Aug 20, 2026

LOT-0004

Udbudsnummer 4

Udbudsnummeret (delkontrakten) omfatter følgende lægemidler: ATC Code: L02AE02 · Generisk navn: Leuprorelin · Dispenseringsform: Injektionsvæske · Styrke: 22,5 mg · Enhedsværdi: 0,134 mg · Mængde i enheder: 2687. Hvert udbudsnummer anses for en selvstændig delkontrakt og udbydes uafhængigt af de øvrige udbudsnumre. En leverandør kan således vælge at give tilbud på ét, flere eller alle udbudsnumre, og tildeling sker separat for hvert enkelt udbudsnummer. En leverandør kan således tildeles en, flere eller alle delkontrakter. Der henvises til udbudsbetingelserne, herunder om afgivelse af tilbud under de enkelte udbudsnumre. Under betegnelsen "mængde i enheder" ovenfor er angivet et skønnet forbrug af lægemidlerne under udbudsnummeret, men det reelle forbrug kan afvige væsentligt derfra. Dette må leverandørerne påregne. Baggrunden herfor er, at der er tale om lægemidler til patientbehandling på de offentlige sygehuse, hvor patientens behov skal imødekommes. For nærmere beskrivelse henvises der til udbudsbetingelserne og rammeaftalen.

SuppliesFrameworkEU fundedElectronic submission

EUR 108M

Estimated value

Location

DK011, Denmark

Duration

Mar 2027 - Mar 2030

Category

Pharmaceutical products

Award Criteria

Pris, Der henvises til udbudsbetingelserne pkt. 10

LOT-0005

Udbudsnummer 5

Udbudsnummeret (delkontrakten) omfatter følgende lægemidler: ATC Code: L02AE02 · Generisk navn: Leuprorelin · Dispenseringsform: Injektionsvæske · Styrke: 45 mg · Enhedsværdi: 0,134 mg · Mængde i enheder: 5648173. Hvert udbudsnummer anses for en selvstændig delkontrakt og udbydes uafhængigt af de øvrige udbudsnumre. En leverandør kan således vælge at give tilbud på ét, flere eller alle udbudsnumre, og tildeling sker separat for hvert enkelt udbudsnummer. En leverandør kan således tildeles en, flere eller alle delkontrakter. Der henvises til udbudsbetingelserne, herunder om afgivelse af tilbud under de enkelte udbudsnumre. Under betegnelsen "mængde i enheder" ovenfor er angivet et skønnet forbrug af lægemidlerne under udbudsnummeret, men det reelle forbrug kan afvige væsentligt derfra. Dette må leverandørerne påregne. Baggrunden herfor er, at der er tale om lægemidler til patientbehandling på de offentlige sygehuse, hvor patientens behov skal imødekommes. For nærmere beskrivelse henvises der til udbudsbetingelserne og rammeaftalen.

SuppliesFrameworkEU fundedElectronic submission

EUR 108M

Estimated value

Location

DK011, Denmark

Duration

Mar 2027 - Mar 2030

Category

Pharmaceutical products

Award Criteria

Pris, Der henvises til udbudsbetingelserne pkt. 10

Procurement Details

Publication date
28 Jun 2026
Languages
Danish, Swedish

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
443552-2026

Documents (1)

Similar tenders